Advertisment

Probiotics: A Novel, Non-Invasive Strategy for Colorectal Cancer Prevention and Treatment

author-image
Mason Walker
New Update
NULL

Probiotics: A Novel, Non-Invasive Strategy for Colorectal Cancer Prevention and Treatment

Advertisment

Colorectal cancer (CRC) is a significant global health issue, with an estimated 3.2 million new cases and 1.6 million deaths projected by 2040. As researchers continue to study various prevention and treatment strategies, one area that has shown considerable promise is the use of probiotics. This article explores the potential of probiotics as a safe, innovative and non-invasive strategy for CRC prevention and treatment, with insights from research and clinical studies.

Advertisment

The Role of Probiotics in Colorectal Cancer Prevention

Probiotics, commonly referred to as 'good bacteria', have been found to modulate the gut microbial composition, providing numerous health benefits. According to Prof. Jun Yu from The Chinese University of Hong Kong, probiotics have the power to regulate the intestinal microenvironment, which can help prevent the development of CRC. They work by restoring microbial composition, reinforcing gut barrier integrity, inducing cancer cell apoptosis, inactivating carcinogens, and modulating the host immune response. This makes them an integral part of non-invasive CRC prevention strategies.

Next-Generation Probiotics and Postbiotics

Advertisment

Research in this field is not just limited to traditional probiotics. Next-generation probiotics (NGPs) and postbiotics, which are derived from probiotic bacteria, are also being explored for their potential in CRC prevention. These newer interventions are designed to be more effective and targeted, offering promising results in initial studies. However, before these findings can be translated to clinical practice, further research is needed to evaluate potential risks, optimize delivery methods, and consider intra-patient variability of gut microbial baseline.

The Impact of Probiotics on Tumor Progression and Metastasis

Studies have shown that microbial imbalances and changes in the levels of bacterial metabolites and toxins can promote cancer progression. Probiotics can inhibit tumor development, reduce tumor volume, suppress angiogenesis, and prevent metastasis. The ability of probiotics to modulate an unfavorable microbiome might improve treatment efficacy and reduce treatment-related toxicities, bringing significant clinical benefits for patients with metastatic cancer.

Advertisment

Probiotics as a Supplement to Chemo- and Immune-Therapy

Probiotics not only play a role in CRC prevention but can also supplement conventional CRC treatments like chemotherapy and immunotherapy. They can enhance the effectiveness of these treatments, making them a valuable adjuvant therapy. For example, a study conducted by the Sahlgrenska Academy at University of Gothenburg, in collaboration with DuPont Nutrition & Health, demonstrated that probiotics could positively change the intestinal microbiota in patients with colon cancer, leading to an increase in butyrate-producing bacteria, known to suppress the growth of colon cancer cells.

The Future of Probiotics in Colorectal Cancer Prevention and Treatment

While the role of individual bacteria and the gut microbial community in CRC development is yet to be definitively identified, current research suggests that host lifestyle factors, microbiome community interactions, and immune responses may all play critical roles in the process. As such, probiotics hold significant therapeutic potential for CRC prevention and treatment. The ongoing exploration of probiotics, NGPs, and postbiotics promises to yield more effective and targeted interventions for CRC in the future.

Advertisment
Chat with Dr. Medriva !